French pharmaceutical company buys Meriden-based Protein Sciences


MERIDEN, Conn. (WTNH) — A French pharmaceutical company is buying Meriden-based Protein Sciences.

Sanofi made the announcement on Tuesday that it is paying up to $750 million for the privately held vaccines biotech company.

Protein Sciences produces Flublok, the only non-egg based flu vaccine approved by the FDA.

Manon Cox, who heads up Protein Sciences, says the company was looking for an opportunity to grow more of its business.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

Don't Miss

More Don't Miss